Results summary | View all lists in GO:BiolProc | View all genes in G03AC.profile.ud50 |
Development of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. enrichment: 1.52-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
210395_X_AT | MYL4 | D | myosin, light chain 4, alkali; atrial, embryonic | ||||||||||
214571_AT | FGF3 | G | D | C | S | fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) | |||||||
215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
220266_S_AT | KLF4 | G | D | R | Kruppel-like factor 4 (gut) | ||||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
202221_S_AT | EP300 | G | D | X | P | R | S | E1A binding protein p300 | |||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
203977_AT | TAZ | D | tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) | ||||||||||
206115_AT | EGR3 | D | R | C | early growth response 3 | ||||||||
210512_S_AT | VEGFA | G | D | X | S | vascular endothelial growth factor A | |||||||
205842_S_AT | JAK2 | D | P | S | Janus kinase 2 (a protein tyrosine kinase) | ||||||||
211421_S_AT | RET | D | P | C | S | ret proto-oncogene | |||||||
211177_S_AT | TXNRD2 | D | X | E | thioredoxin reductase 2 |